PRASOL CHEMICALS IPO
PRASOL CHEMICALS is a MAINBOARD IPO with a current status of CLOSED. The price band is 643 - 676. The issue opens on 08 SEP and closes on 10 SEP. The listing date is 16 SEP.
Price Band
643 - 676
Unofficial GMP
₹0
Lot Size
22 shares
Minimum Investment
₹14,872
PRASOL CHEMICALS IPO GMP
The latest available GMP is ₹0. Grey Market Premium is unofficial, may change frequently and does not guarantee the listing price, listing gains or investment returns.
Estimated Listing Price
₹676.00
Estimated Gain
0.0%
PRASOL CHEMICALS IPO GMP History
0
10 SEP
0
11 SEP
PRASOL CHEMICALS IPO Details
- IPO Type
- MAINBOARD
- Status
- CLOSED
- Price Band
- 643 - 676
- Issue Size
- 500 CR
- Issue Type
- Book Build Issue
- Fresh Issue
- ₹80.00 Cr
- Offer for Sale
- ₹420.00 Cr
- Face Value
- 2
- Lot Size
- 22
- Minimum Investment
- 14,872
- Exchange
- BSE $ NSE
- Registrar
- Kfin Technologies Ltd.
- Lead Managers
- Dam Capital Advisors Ltd.
PRASOL CHEMICALS IPO Dates
- Open Date
- 08 SEP
- Close Date
- 10 SEP
- Allotment Date
- 11 SEP
- Refund Date
- 15 SEP
- Demat Credit Date
- 15 SEP
- Listing Date
- 16 SEP
PRASOL CHEMICALS IPO Subscription
- QIB
- 5.63x
- NII / HNI
- 1.27x
- Retail
- 1.52x
- Total
- 2.64x
PRASOL CHEMICALS IPO Financials
Revenue
FY2026
₹1,232.59 Cr
+21.74% vs FY2025
PAT
FY2026
₹83.12 Cr
+90.77% vs FY2025
Total Assets
FY2026
₹839.27 Cr
+16.07% vs FY2025
| Particulars | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | 876.56 | 1,012.49 | 1,232.59 |
| Net Profit | 18.13 | 43.57 | 83.12 |
| Total Assets | 626.36 | 723.09 | 839.27 |
PRASOL CHEMICALS IPO Valuation
- Valuation
- EXPENSIVE
PRASOL CHEMICALS IPO Market Lot
| Category | Lots | Shares | Investment |
|---|---|---|---|
| Retail Minimum | 1 | 22 | ₹14,872 |
| Retail Maximum | 13 | 286 | ₹1,93,336 |
| Small HNI | 14 | 308 | ₹2,08,208 |
| Big HNI | 68 | 1,496 | ₹10,11,296 |
PRASOL CHEMICALS IPO Reservation
- QIB
- 50%
- NII / HNI
- 15%
- Retail
- 35%
PRASOL CHEMICALS Company Overview
Prasol Chemicals Limited, incorporated in 1992, is a specialty chemicals manufacturer with more than three decades of operating experience. The company is primarily engaged in manufacturing acetone-based specialty chemicals, phosphorus-based specialty chemicals and other customised specialty chemicals involving differentiated and complex chemistries. As of July 2026, its portfolio comprised 150+ specialty chemical products, while around 40 additional products were under development. The company's products cater to a diversified range of applications, including performance chemicals such as lubricant additives and mining chemicals; paints, inks, construction and adhesives (PICA); pharmaceuticals; agrochemicals; and home & personal care. Its portfolio included 21 acetone-based specialty chemicals, 53 phosphorus-based specialty chemicals and 76 other specialty chemicals. Prasol operates two manufacturing facilities in Maharashtra, at Khopoli and Mahad, with an aggregate installed capacity of approximately 98,644 MT per annum. The company has developed a sizeable international presence, serving 1,600+ customers across 69 countries. Exports contributed approximately 27.29% of FY2026 revenue, demonstrating a meaningful global presence while India remains its largest market. The company's competitive positioning is also supported by its product development capabilities. It operates an in-house R&D team and continues to develop customised products for different end-use industries. During CY2022–CY2025, it was reportedly India's largest importer of acetone for manufacturing acetone-based specialty chemicals and the only manufacturer of isophorone in India.
PRASOL CHEMICALS Business Model
Prasol Chemicals follows a forward-integrated specialty chemicals manufacturing model. Its business can broadly be divided into three product categories: acetone-based specialty chemicals, phosphorus-based specialty chemicals and other specialty/customised chemicals. In FY2026, acetone-based specialty chemicals contributed about 42.75%, phosphorus-based specialty chemicals about 38.30%, and other specialty chemicals about 18.33% of revenue. The company manufactures products used across multiple industries rather than depending entirely on a single end-use sector. Its customers operate in lubricant additives, mining chemicals, paints and coatings, construction chemicals, adhesives, pharmaceuticals, agrochemicals, cosmetics and home & personal-care industries. Prasol combines manufacturing, R&D and customised product development to address customers' specific chemical requirements. Its geographic reach is another important part of the business model. Prasol serves customers in 69 countries, while maintaining a significant domestic business. The broad customer and application base provides diversification, although the company continues to have meaningful exposure to its acetone-based product segment and imported raw materials.
PRASOL CHEMICALS Objects of the Issue
| Object | Amount | Purpose | | ---------------------------------------- | --------------------------: | ------------------------------------------------------------------------------------------------------ | | **Repayment / prepayment of borrowings** | **₹60 Crore** | Repayment or pre-payment, in full or in part, of certain outstanding borrowings availed by the company | | **General Corporate Purposes** | **Balance eligible amount** | General corporate requirements, subject to applicable IPO regulations | | **OFS proceeds** | **Nil to Company** | OFS proceeds are received by selling shareholders and not by Prasol Chemicals |
PRASOL CHEMICALS Strengths
1. Diversified Specialty Chemical Portfolio: Prasol has developed a portfolio of more than 150 specialty chemical products across acetone derivatives, phosphorus derivatives and other differentiated/customised chemicals. This allows the company to address multiple industrial applications and reduces complete dependence on a single end-use industry. 2. Large and Diversified Customer Base: The company serves more than 1,600 customers and has operations extending across 69 countries. No single customer contributed more than 5% of total income in FY2026, according to IPO-related disclosures, which limits dependence on any one customer. 3. Strong R&D Capabilities: Prasol has developed in-house research and product-development capabilities. Its R&D team consisted of 37 members, including PhD holders and chemists, and the company had approximately 40 products at various stages of development. This capability can support customised products and future portfolio expansion. 4. Established Manufacturing Infrastructure: Its Khopoli and Mahad manufacturing facilities have combined installed capacity of approximately 98,644 MT per annum, providing scale to manufacture a broad portfolio of specialty chemicals. 5. Improving Financial Performance: Total income increased from approximately ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026, while PAT increased from approximately ₹18.14 crore to ₹83.12 crore over the same period. This indicates substantial improvement in profitability and operating performance.
PRASOL CHEMICALS Risks
1. Manufacturing Facility Concentration: Prasol's manufacturing operations are concentrated in two facilities in Maharashtra. Any accident, equipment failure, regulatory restriction, environmental issue or prolonged shutdown at these facilities could materially affect production and financial performance. This risk is particularly relevant because the Mahad facility previously faced an MPCB-directed shutdown between October 2023 and May 2024. 2. Hazardous Nature of Operations: Specialty chemical manufacturing involves handling hazardous, corrosive and flammable raw materials, intermediates and finished products. Accidents, leakages, fires or failures to comply with environmental and safety regulations could result in production disruptions, liabilities and reputational damage. 3. Raw Material and Import Dependency: Imports represented approximately 65.96% of raw-material procurement cost in FY2026. This exposes Prasol to fluctuations in foreign-exchange rates, international chemical prices, logistics disruptions and geopolitical or supply-chain issues. 4. Product Concentration: Despite having more than 150 products, acetone-based specialty chemicals contributed around 42.75% of FY2026 revenue. A significant downturn in demand or adverse pricing conditions in this product category could therefore affect overall performance. 5. Supplier Concentration and Capacity Risk: The company's top suppliers account for a meaningful share of raw-material procurement, creating dependency on key suppliers. In addition, utilisation at the Mahad facility has historically been relatively low, despite improving from earlier levels. These factors may affect operating efficiency and margins. 6. IPO Valuation Risk: At the upper price band, the IPO has been reported at roughly 48× FY2026 earnings, meaning investors are paying a relatively high valuation despite operational, raw-material and manufacturing risks. Strong future earnings growth may therefore be required to justify the valuation.
PRASOL CHEMICALS Frequently Asked Questions
What is the PRASOL CHEMICALS IPO price band?
The PRASOL CHEMICALS IPO price band is 643 - 676.
What is the latest PRASOL CHEMICALS IPO GMP?
The latest available PRASOL CHEMICALS IPO GMP in the IPOWEB database is ₹0. GMP is unofficial and does not guarantee a listing gain.
When does the PRASOL CHEMICALS IPO open and close?
The PRASOL CHEMICALS IPO opens on 08 SEP and closes on 10 SEP.
When is the PRASOL CHEMICALS IPO allotment date?
The PRASOL CHEMICALS IPO allotment date is 11 SEP.
When is the PRASOL CHEMICALS IPO listing date?
The PRASOL CHEMICALS IPO listing date is 16 SEP.
What is the PRASOL CHEMICALS IPO subscription?
The latest total subscription available for the PRASOL CHEMICALS IPO is 2.64x.